This brand name is authorized in Mexico
The drug ENCONTROPINA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Butylscopolamine
UNII 0GH9JX37C8 - BUTYLSCOPOLAMINE BROMIDE
|
|
Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. |
|
2
Ketorolac
UNII YZI5105V0L - KETOROLAC
|
|
Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 076M2012, 077M2012 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
